What is the recommended ceftazidime dose for an adult patient with normal renal function who has a Pseudomonas urinary tract infection confirmed by culture and sensitivity?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 26, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ceftazidime Dosing for Pseudomonas Urinary Tract Infection

For an adult patient with normal renal function and culture-confirmed Pseudomonas urinary tract infection, administer ceftazidime 500 mg to 1 gram intravenously every 8 hours for complicated UTI. 1

Dosing Algorithm Based on UTI Complexity

Complicated UTI (Most Pseudomonas UTIs Fall Here)

  • Standard dose: 500 mg IV or IM every 8 to 12 hours 1
  • Alternative: 1 gram IV every 8 hours for more severe presentations 1
  • This dosing achieves urinary concentrations of approximately 2,100 mcg/mL after 500 mg IM and 12,000 mcg/mL after 2 g IV 1

Uncomplicated UTI (Rare for Pseudomonas)

  • 250 mg IV or IM every 12 hours 1
  • However, Pseudomonas UTIs are typically classified as complicated due to the organism's inherent resistance patterns 2

Key Clinical Considerations

Why Pseudomonas UTI is Usually "Complicated"

The 2024 European Association of Urology guidelines classify UTIs with multidrug-resistant organisms (including Pseudomonas) as complicated UTIs, regardless of anatomic factors 2. This automatically places most Pseudomonas UTIs in the higher dosing category.

Treatment Duration

  • Continue for 2 days after signs and symptoms resolve 1
  • Complicated infections may require longer therapy 1
  • Historical data suggests 5-7 days is typically adequate for UTI 3, 4

Monitoring for Treatment Failure

A critical pitfall with Pseudomonas is emergence of resistance during therapy. Studies show resistance development in approximately 25-33% of Pseudomonas strains during ceftazidime monotherapy 5, 6. If clinical response is inadequate after 48-72 hours, consider:

  • Increasing dose to 2 grams IV every 8 hours 1
  • Adding a second agent (combination therapy shows superior resistance suppression) 6
  • Reassessing culture sensitivities

Renal Function Adjustments

If creatinine clearance drops below 50 mL/min during therapy:

  • CrCl 31-50: 1 gram every 12 hours 1
  • CrCl 16-30: 1 gram every 24 hours 1
  • CrCl 6-15: 500 mg every 24 hours 1

The FDA label emphasizes using the lower of either the standard UTI dose or the renal-adjusted dose 1.

Pharmacokinetic Rationale

Ceftazidime achieves excellent urinary concentrations with approximately 80-90% excreted unchanged in urine 1. Peak serum levels of 42 mcg/mL after 500 mg IV and 69 mcg/mL after 1 gram IV are achieved, with a half-life of approximately 1.9-2.1 hours in normal renal function 1, 7.

Common Pitfall: Underdosing

Historical trials using 250 mg twice daily showed the lowest cure rates, particularly for Pseudomonas (53.3% cure rate) 3. The 500 mg to 1 gram every 8 hours regimen provides more reliable eradication 4.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.